Innovation Pharmaceuticals Inc (IPIX)

[To infinity and beyond!]

Agree with you that primary outcome now for K is MTD and safety.

But if the company has press releases about p21 levels and about patient success stories, then I think that more is at stake, even so early on.

Forgetting about the real outcomes: if CTIX says p21 steadily up as dosing of K goes up- as we expected- and says that patients in later cohorts continue to have disappearing metastatic lesions, the share price will rise.

And it will fall if they say the opposite, even as safety and MTD are set. Even though B looks great.

The long run is another story of course.

I apologize if I am looking through posts too quickly-